{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:32:16Z","timestamp":1794933136761,"version":"4.9.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NSF SBIR","award":["2032325"],"award-info":[{"award-number":["2032325"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Unlike the injectable vaccines, intranasal lipid nanoparticle (NP)-based adjuvanted vaccine is promising to protect against local infection and viral transmission.  Infection of ferrets with SARS-CoV-2 results in typical respiratory disease and pathology akin to in humans, suggesting that the ferret model may be ideal for intranasal vaccine studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We developed SARS-CoV-2 subunit vaccine containing both Spike receptor binding domain (S-RBD) and Nucleocapsid (N) proteins (NP-COVID-Proteins) or their mRNA (NP-COVID-mRNA) and NP-monosodium urate adjuvant. Both the candidate vaccines in intranasal vaccinated aged ferrets substantially reduced the replicating virus in the entire respiratory tract. Specifically, the NP-COVID-Proteins vaccine did relatively better in clearing the virus from the nasal passage early post challenge infection. The immune gene expression in NP-COVID-Proteins vaccinates indicated increased levels of mRNA of IFN\u03b1, MCP1 and IL-4 in lungs and nasal turbinates, and IFN\u03b3 and IL-2 in lungs; while proinflammatory mediators IL-1\u03b2 and IL-8 mRNA levels in lungs were downregulated. In NP-COVID-Proteins vaccinated ferrets S-RBD and N protein specific IgG antibodies in the serum were substantially increased at both day post challenge (DPC) 7 and DPC 14, while the virus neutralizing antibody titers were relatively better induced by mRNA versus the proteins-based vaccine. In conclusion, intranasal NP-COVID-Proteins vaccine induced balanced Th1 and Th2 immune responses in the respiratory tract, while NP-COVID-mRNA vaccine primarily elicited antibody responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Intranasal NP-COVID-Proteins vaccine may be an ideal candidate to elicit increased breadth of immunity against SARS-CoV-2 variants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-023-01816-3","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T07:10:35Z","timestamp":1677049835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines"],"prefix":"10.1186","volume":"21","author":[{"given":"Patricia A.","family":"Boley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Schrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kush Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerupaxagouda","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raksha","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoqi Mark","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudra","family":"Channappanavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gourapura J.","family":"Renukaradhya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"1816_CR1","first-page":"1","volume":"38","author":"E Prompetchara","year":"2020","unstructured":"Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38:1\u20139.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"1816_CR2","doi-asserted-by":"crossref","unstructured":"Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick L, Rattigan SM, et al. A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease, Infectious Diseases (except HIV\/AIDS). 2020.","DOI":"10.1101\/2020.04.14.20065771"},{"key":"1816_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104114","volume":"353","author":"JG Melgaco","year":"2020","unstructured":"Melgaco JG, Azamor T, Ano Bom APD. Protective immunity after COVID-19 has been questioned: what can we do without SARS-CoV-2-IgG detection? Cell Immunol. 2020;353: 104114.","journal-title":"Cell Immunol"},{"key":"1816_CR4","doi-asserted-by":"crossref","unstructured":"Wu F, Wang A, Liu M, Wang Q, Chen J, Xia S, et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications, Infectious Diseases (except HIV\/AIDS). 2020.","DOI":"10.1101\/2020.03.30.20047365"},{"key":"1816_CR5","doi-asserted-by":"crossref","unstructured":"Thevarajan I, Nguyen TH, Koutsakos M, Druce J, Caly L, van de Sandt CE, et al. Breadth of concomitant immune responses underpinning viral clearance and patient recovery in a non-severe case of COVID-19, Infectious Diseases (except HIV\/AIDS). 2020.","DOI":"10.1101\/2020.02.20.20025841"},{"key":"1816_CR6","doi-asserted-by":"crossref","unstructured":"Weiskopf D, Schmitz KS, Raadsen MP, Grifoni A, Okba NMA, Endeman H, et al. Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome, Infectious Diseases (except HIV\/AIDS). 2020.","DOI":"10.1101\/2020.04.11.20062349"},{"key":"1816_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.vaccine.2005.08.058","volume":"24","author":"T Bauer","year":"2006","unstructured":"Bauer T, Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine. 2006;24:572\u20137.","journal-title":"Vaccine"},{"key":"1816_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nri1777","volume":"6","author":"MR Neutra","year":"2006","unstructured":"Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol. 2006;6:148\u201358.","journal-title":"Nat Rev Immunol"},{"key":"1816_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1080\/14712598.2020.1767062","volume":"20","author":"L Moreno-Fierros","year":"2020","unstructured":"Moreno-Fierros L, Garcia-Silva I, Rosales-Mendoza S. Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity? Expert Opin Biol Ther. 2020;20:831.","journal-title":"Expert Opin Biol Ther"},{"key":"1816_CR10","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1128\/IAI.68.10.5764-5770.2000","volume":"68","author":"A Bacon","year":"2000","unstructured":"Bacon A, Makin J, Sizer PJ, Jabbal-Gill I, Hinchcliffe M, Illum L, et al. Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens. Infect Immun. 2000;68:5764\u201370.","journal-title":"Infect Immun"},{"key":"1816_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3109\/03639040903382673","volume":"36","author":"U Bertram","year":"2010","unstructured":"Bertram U, Bernard MC, Haensler J, Maincent P, Bodmeier R. In situ gelling nasal inserts for influenza vaccine delivery. Drug Dev Ind Pharm. 2010;36:581\u201393.","journal-title":"Drug Dev Ind Pharm"},{"key":"1816_CR12","doi-asserted-by":"publisher","first-page":"6699","DOI":"10.2147\/IJN.S178809","volume":"13","author":"S Dhakal","year":"2018","unstructured":"Dhakal S, Cheng X, Salcido J, Renu S, Bondra K, Lakshmanappa YS, et al. Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs. Int J Nanomedicine. 2018;13:6699\u2013715.","journal-title":"Int J Nanomedicine"},{"key":"1816_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-bioeng-071811-150054","volume":"14","author":"KA Woodrow","year":"2012","unstructured":"Woodrow KA, Bennett KM, Lo DD. Mucosal vaccine design and delivery. Annu Rev Biomed Eng. 2012;14:17\u201346.","journal-title":"Annu Rev Biomed Eng"},{"key":"1816_CR14","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/eji.200737169","volume":"37","author":"A Heit","year":"2007","unstructured":"Heit A, Schmitz F, Haas T, Busch DH, Wagner H. Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity. Eur J Immunol. 2007;37:2063\u201374.","journal-title":"Eur J Immunol"},{"key":"1816_CR15","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.4049\/jimmunol.1002084","volume":"187","author":"C Schliehe","year":"2011","unstructured":"Schliehe C, Redaelli C, Engelhardt S, Fehlings M, Mueller M, van Rooijen N, et al. CD8- dendritic cells and macrophages cross-present poly(D, L-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo. J Immunol. 2011;187:2112\u201321.","journal-title":"J Immunol"},{"key":"1816_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","volume":"298","author":"C Foged","year":"2005","unstructured":"Foged C, Brodin B, Frokjaer S, Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm. 2005;298:315\u201322.","journal-title":"Int J Pharm"},{"key":"1816_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jconrel.2016.12.039","volume":"247","author":"S Dhakal","year":"2017","unstructured":"Dhakal S, Hiremath J, Bondra K, Lakshmanappa YS, Shyu DL, Ouyang K, et al. Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs. J Control Release. 2017;247:194\u2013205.","journal-title":"J Control Release"},{"key":"1816_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151922","volume":"11","author":"J Hiremath","year":"2016","unstructured":"Hiremath J, Kang KI, Xia M, Elaish M, Binjawadagi B, Ouyang K, et al. Entrapment of H1N1 influenza virus derived conserved peptides in PLGA nanoparticles enhances T cell response and vaccine efficacy in pigs. PLoS ONE. 2016;11: e0151922.","journal-title":"PLoS ONE"},{"key":"1816_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161:505\u201322.","journal-title":"J Control Release"},{"key":"1816_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157041","volume":"11","author":"F Zhang","year":"2016","unstructured":"Zhang F, Peng B, Chang H, Zhang R, Lu F, Wang F, et al. Intranasal immunization of mice to avoid interference of maternal antibody against H5N1 infection. PLoS ONE. 2016;11: e0157041.","journal-title":"PLoS ONE"},{"key":"1816_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.584299","volume":"12","author":"S Renu","year":"2021","unstructured":"Renu S, Feliciano-Ruiz N, Patil V, Schrock J, Han Y, Ramesh A, et al. Immunity and protective efficacy of mannose conjugated chitosan-based influenza nanovaccine in maternal antibody positive pigs. Front Immunol. 2021;12: 584299.","journal-title":"Front Immunol"},{"key":"1816_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","volume":"499","author":"M Kanekiyo","year":"2013","unstructured":"Kanekiyo M, Wei CJ, Yassine HM, McTamney PM, Boyington JC, Whittle JR, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 2013;499:102\u20136.","journal-title":"Nature"},{"key":"1816_CR23","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1016\/j.vaccine.2021.03.006","volume":"39","author":"Y Du","year":"2021","unstructured":"Du Y, Xu Y, Feng J, Hu L, Zhang Y, Zhang B, et al. Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse. Vaccine. 2021;39:2280\u20137.","journal-title":"Vaccine"},{"key":"1816_CR24","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3390\/pathogens11091035","volume":"11","author":"WC Huang","year":"2022","unstructured":"Huang WC, Chiem K, Martinez-Sobrido L, Lovell JF. Intranasal immunization with liposome-displayed receptor-binding domain induces mucosal immunity and protection against SARS-CoV-2. Pathogens. 2022;11:1035.","journal-title":"Pathogens"},{"key":"1816_CR25","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12916-022-02661-1","volume":"20","author":"JF Lovell","year":"2022","unstructured":"Lovell JF, Baik YO, Choi SK, Lee C, Lee JY, Miura K, et al. Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine. BMC Med. 2022;20:462.","journal-title":"BMC Med"},{"key":"1816_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3389\/fimmu.2018.00934","volume":"9","author":"S Dhakal","year":"2018","unstructured":"Dhakal S, Renu S, Ghimire S, Shaan Lakshmanappa Y, Hogshead BT, Feliciano-Ruiz N, et al. Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs. Front Immunol. 2018;9:934.","journal-title":"Front Immunol"},{"key":"1816_CR27","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/jps.21065","volume":"97","author":"P Malyala","year":"2008","unstructured":"Malyala P, Chesko J, Ugozzoli M, Goodsell A, Zhou F, Vajdy M, et al. The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles. J Pharm Sci. 2008;97:1155\u201364.","journal-title":"J Pharm Sci"},{"key":"1816_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-4598-10-3","volume":"10","author":"A Bolhassani","year":"2011","unstructured":"Bolhassani A, Safaiyan S, Rafati S. Improvement of different vaccine delivery systems for cancer therapy. Mol Cancer. 2011;10:3.","journal-title":"Mol Cancer"},{"key":"1816_CR29","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1016\/j.vaccine.2015.04.102","volume":"33","author":"GJ Renukaradhya","year":"2015","unstructured":"Renukaradhya GJ, Meng XJ, Calvert JG, Roof M, Lager KM. Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: current status and future direction. Vaccine. 2015;33:3065\u201372.","journal-title":"Vaccine"},{"key":"1816_CR30","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1073\/pnas.1112648109","volume":"109","author":"JJ Moon","year":"2012","unstructured":"Moon JJ, Suh H, Li AV, Ockenhouse CF, Yadava A, Irvine DJ. Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction. Proc Natl Acad Sci U S A. 2012;109:1080\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1816_CR31","first-page":"1519","volume":"9","author":"B Binjawadagi","year":"2014","unstructured":"Binjawadagi B, Dwivedi V, Manickam C, Ouyang K, Torrelles JB, Renukaradhya GJ. An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination. Int J Nanomed. 2014;9:1519\u201335.","journal-title":"Int J Nanomed"},{"key":"1816_CR32","first-page":"679","volume":"9","author":"B Binjawadagi","year":"2014","unstructured":"Binjawadagi B, Dwivedi V, Manickam C, Ouyang K, Wu Y, Lee LJ, et al. Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs. Int J Nanomed. 2014;9:679\u201394.","journal-title":"Int J Nanomed"},{"key":"1816_CR33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","volume":"124","author":"B Pulendran","year":"2006","unstructured":"Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell. 2006;124:849\u201363.","journal-title":"Cell"},{"key":"1816_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373\u201384.","journal-title":"Nat Immunol"},{"key":"1816_CR35","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.1016\/j.vaccine.2009.05.091","volume":"27","author":"HH Salman","year":"2009","unstructured":"Salman HH, Irache JM, Gamazo C. Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination. Vaccine. 2009;27:4784\u201390.","journal-title":"Vaccine"},{"key":"1816_CR36","doi-asserted-by":"publisher","first-page":"39884","DOI":"10.1038\/srep39884","volume":"7","author":"TT Braga","year":"2017","unstructured":"Braga TT, Forni MF, Correa-Costa M, Ramos RN, Barbuto JA, Branco P, et al. Soluble uric acid activates the NLRP3 inflammasome. Sci Rep. 2017;7:39884.","journal-title":"Sci Rep"},{"key":"1816_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00005-010-0082-1","volume":"58","author":"G Ng","year":"2010","unstructured":"Ng G, Chau EM, Shi Y. Recent developments in immune activation by uric acid crystals. Arch Immunol Ther Exp. 2010;58:273\u20137.","journal-title":"Arch Immunol Ther Exp"},{"key":"1816_CR38","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/15257770.2011.597368","volume":"30","author":"I Sakamaki","year":"2011","unstructured":"Sakamaki I, Inai K, Tsutani H. Safety of intradermal injection of monosodium urate crystals as a vaccine carrier in volunteers. Nucleosides Nucleotides Nucleic Acids. 2011;30:1077\u201384.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"1816_CR39","unstructured":"Cheng XG, Zhong GM, Mcdonough J, MacNaughton M. In vivo evaluation of MSU crystals as an adjuvant. Vaccine Development Center of San Antonio Conference, Nov 13\u201314, 20142014."},{"key":"1816_CR40","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.chom.2020.03.023","volume":"27","author":"YI Kim","year":"2020","unstructured":"Kim YI, Kim SG, Kim SM, Kim EH, Park SJ, Yu KM, et al. Infection and rapid transmission of SARS-CoV-2 in ferrets. Cell Host Microbe. 2020;27:704\u20139.","journal-title":"Cell Host Microbe"},{"key":"1816_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add9947","volume":"7","author":"EJ Topol","year":"2022","unstructured":"Topol EJ, Iwasaki A. Operation nasal vaccine-lightning speed to counter COVID-19. Sci Immunol. 2022;7: eadd9947.","journal-title":"Sci Immunol."},{"key":"1816_CR42","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","volume":"15","author":"S Sheikh-Mohamed","year":"2022","unstructured":"Sheikh-Mohamed S, Isho B, Chao GYC, Zuo M, Cohen C, Lustig Y, et al. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection. Mucosal Immunol. 2022;15:799\u2013808.","journal-title":"Mucosal Immunol"},{"key":"1816_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.809244","volume":"12","author":"P Mistry","year":"2021","unstructured":"Mistry P, Barmania F, Mellet J, Peta K, Strydom A, Viljoen IM, et al. SARS-CoV-2 variants, vaccines, and host immunity. Front Immunol. 2021;12: 809244.","journal-title":"Front Immunol"},{"key":"1816_CR44","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.7150\/ijbs.59233","volume":"17","author":"JW Park","year":"2021","unstructured":"Park JW, Lagniton PNP, Liu Y, Xu RH. mRNA vaccines for COVID-19: what, why and how. Int J Biol Sci. 2021;17:1446\u201360.","journal-title":"Int J Biol Sci"},{"key":"1816_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100208","volume":"10","author":"P Naaber","year":"2021","unstructured":"Naaber P, Tserel L, Kangro K, Sepp E, Jurjenson V, Adamson A, et al. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. Lancet Reg Health Eur. 2021;10: 100208.","journal-title":"Lancet Reg Health Eur"},{"key":"1816_CR46","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","volume":"592","author":"Z Wang","year":"2021","unstructured":"Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592:616\u201322.","journal-title":"Nature"},{"key":"1816_CR47","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.1016\/j.vaccine.2005.06.031","volume":"23","author":"M Manocha","year":"2005","unstructured":"Manocha M, Pal PC, Chitralekha KT, Thomas BE, Tripathi V, Gupta SD, et al. Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target. Vaccine. 2005;23:5599\u2013617.","journal-title":"Vaccine"},{"key":"1816_CR48","unstructured":"Lisa Schnirring CN, Feb 21, 2018. CDC vaccine panel brings back FluMist for 2018\u201319 season. http:\/\/www.cidrapumnedu\/news-perspective\/2018\/02\/cdc-vaccine-panel-brings-back-flumist-2018-19-season. 2018."},{"key":"1816_CR49","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1128\/jvi.69.2.1339-1343.1995","volume":"69","author":"MB Mazanec","year":"1995","unstructured":"Mazanec MB, Coudret CL, Fletcher DR. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol. 1995;69:1339\u201343.","journal-title":"J Virol"},{"key":"1816_CR50","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1073\/pnas.1503885112","volume":"112","author":"T Suzuki","year":"2015","unstructured":"Suzuki T, Kawaguchi A, Ainai A, Tamura S, Ito R, Multihartina P, et al. Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus. Proc Natl Acad Sci USA. 2015;112:7809\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1816_CR51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2172-11-65","volume":"11","author":"BS Shim","year":"2010","unstructured":"Shim BS, Park SM, Quan JS, Jere D, Chu H, Song MK, et al. Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus\/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses. BMC Immunol. 2010;11:65.","journal-title":"BMC Immunol"},{"key":"1816_CR52","doi-asserted-by":"publisher","first-page":"948","DOI":"10.4049\/jimmunol.180.2.948","volume":"180","author":"L Du","year":"2008","unstructured":"Du L, Zhao G, Lin Y, Sui H, Chan C, Ma S, et al. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. J Immunol. 2008;180:948\u201356.","journal-title":"J Immunol"},{"key":"1816_CR53","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1016\/j.vaccine.2007.06.017","volume":"25","author":"MC Hu","year":"2007","unstructured":"Hu MC, Jones T, Kenney RT, Barnard DL, Burt DS, Lowell GH. Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice. Vaccine. 2007;25:6334\u201340.","journal-title":"Vaccine"},{"key":"1816_CR54","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/mi.2008.2","volume":"1","author":"H Kamijuku","year":"2008","unstructured":"Kamijuku H, Nagata Y, Jiang X, Ichinohe T, Tashiro T, Mori K, et al. Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol. 2008;1:208\u201318.","journal-title":"Mucosal Immunol"},{"key":"1816_CR55","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1073\/pnas.0813309106","volume":"106","author":"C Guillonneau","year":"2009","unstructured":"Guillonneau C, Mintern JD, Hubert FX, Hurt AC, Besra GS, Porcelli S, et al. Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc Natl Acad Sci USA. 2009;106:3330\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1816_CR56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-065X.2010.00974.x","volume":"239","author":"PR Dormitzer","year":"2011","unstructured":"Dormitzer PR, Galli G, Castellino F, Golding H, Khurana S, Del Giudice G, et al. Influenza vaccine immunology. Immunol Rev. 2011;239:167\u201377.","journal-title":"Immunol Rev"},{"key":"1816_CR57","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.1016\/j.vaccine.2019.07.034","volume":"37","author":"CS Eickhoff","year":"2019","unstructured":"Eickhoff CS, Blazevic A, Killoran EA, Morris MS, Hoft DF. Induction of mycobacterial protective immunity by sublingual BCG vaccination. Vaccine. 2019;37:5364\u201370.","journal-title":"Vaccine"},{"key":"1816_CR58","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1016\/j.vaccine.2013.12.043","volume":"32","author":"S Gallorini","year":"2014","unstructured":"Gallorini S, Taccone M, Bonci A, Nardelli F, Casini D, Bonificio A, et al. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses. Vaccine. 2014;32:2382\u20138.","journal-title":"Vaccine"},{"key":"1816_CR59","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jsps.2015.02.025","volume":"24","author":"B Karolewicz","year":"2016","unstructured":"Karolewicz B. A review of polymers as multifunctional excipients in drug dosage form technology. Saudi Pharm J. 2016;24:525\u201336.","journal-title":"Saudi Pharm J."},{"key":"1816_CR60","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1163\/156856295X00175","volume":"6","author":"E Piskin","year":"1995","unstructured":"Piskin E. Biodegradable polymers as biomaterials. J Biomater Sci Polym Ed. 1995;6:775\u201395.","journal-title":"J Biomater Sci Polym Ed"},{"key":"1816_CR61","volume-title":"Degradable polymers","author":"E Piskin","year":"2002","unstructured":"Piskin E. Biodegradable polymers in medicine. In: Scott G, editor. Degradable polymers. Dordrecht: Springer; 2002."},{"key":"1816_CR62","unstructured":"Products FsRSPfGPP-BD. https:\/\/www.americanpharmaceuticalreview.com\/Featured-Articles\/188841-FDA-s-Regulatory-Science-Program-for-Generic-PLA-PLGA-Based-Drug-Products\/. 2016."},{"key":"1816_CR63","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3:1377\u201397.","journal-title":"Polymers"},{"key":"1816_CR64","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.actbio.2014.01.033","volume":"10","author":"JU Menon","year":"2014","unstructured":"Menon JU, Ravikumar P, Pise A, Gyawali D, Hsia CC, Nguyen KT. Polymeric nanoparticles for pulmonary protein and DNA delivery. Acta Biomater. 2014;10:2643\u201352.","journal-title":"Acta Biomater"},{"key":"1816_CR65","doi-asserted-by":"publisher","first-page":"11210","DOI":"10.1128\/JVI.01211-10","volume":"84","author":"M Khatri","year":"2010","unstructured":"Khatri M, Dwivedi V, Krakowka S, Manickam C, Ali A, Wang L, et al. Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus. J Virol. 2010;84:11210\u20138.","journal-title":"J Virol"},{"key":"1816_CR66","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.vaccine.2017.01.019","volume":"35","author":"S Dhakal","year":"2017","unstructured":"Dhakal S, Goodman J, Bondra K, Lakshmanappa YS, Hiremath J, Shyu DL, et al. Polyanhydride nanovaccine against swine influenza virus in pigs. Vaccine. 2017;35:1124.","journal-title":"Vaccine"},{"key":"1816_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2020.108611","volume":"242","author":"S Renu","year":"2020","unstructured":"Renu S, Feliciano-Ruiz N, Ghimire S, Han Y, Schrock J, Dhakal S, et al. Poly(I:C) augments inactivated influenza virus-chitosan nanovaccine induced cell mediated immune response in pigs vaccinated intranasally. Vet Microbiol. 2020;242: 108611.","journal-title":"Vet Microbiol"},{"key":"1816_CR68","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13567-019-0712-5","volume":"50","author":"S Dhakal","year":"2019","unstructured":"Dhakal S, Renukaradhya GJ. Nanoparticle-based vaccine development and evaluation against viral infections in pigs. Vet Res. 2019;50:90.","journal-title":"Vet Res"},{"key":"1816_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2019.108401","volume":"237","author":"S Dhakal","year":"2019","unstructured":"Dhakal S, Ghimire S, Renu S, Ross KA, Lakshmanappa YS, Hogshead BT, et al. Evaluation of CpG-ODN-adjuvanted polyanhydride-based intranasal influenza nanovaccine in pigs. Vet Microbiol. 2019;237: 108401.","journal-title":"Vet Microbiol"},{"key":"1816_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cellimm.2018.04.005","volume":"329","author":"S Renu","year":"2018","unstructured":"Renu S, Dhakal S, Kim E, Goodman J, Lakshmanappa YS, Wannemuehler MJ, et al. Intranasal delivery of influenza antigen by nanoparticles, but not NKT-cell adjuvant differentially induces the expression of B-cell activation factors in mice and swine. Cell Immunol. 2018;329:27\u201330.","journal-title":"Cell Immunol"},{"key":"1816_CR71","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.jaci.2021.04.002","volume":"147","author":"KA Risma","year":"2021","unstructured":"Risma KA, Edwards KM, Hummell DS, Little FF, Norton AE, Stallings A, et al. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines. J Allergy Clin Immunol. 2021;147:2075\u201382.","journal-title":"J Allergy Clin Immunol"},{"key":"1816_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.728021","volume":"12","author":"D Forgacs","year":"2021","unstructured":"Forgacs D, Jang H, Abreu RB, Hanley HB, Gattiker JL, Jefferson AM, et al. SARS-CoV-2 mRNA vaccines elicit different responses in immunologically naive and pre-immune humans. Front Immunol. 2021;12: 728021.","journal-title":"Front Immunol"},{"key":"1816_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109504","volume":"36","author":"C Bergamaschi","year":"2021","unstructured":"Bergamaschi C, Terpos E, Rosati M, Angel M, Bear J, Stellas D, et al. Systemic IL-15, IFN-gamma, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients. Cell Rep. 2021;36: 109504.","journal-title":"Cell Rep"},{"key":"1816_CR74","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1002\/jmv.28034","volume":"94","author":"P Peng","year":"2022","unstructured":"Peng P, Deng H, Li Z, Chen Y, Fang L, Hu J, et al. Distinct immune responses in the early phase to natural SARS-CoV-2 infection or vaccination. J Med Virol. 2022;94:5691\u2013701.","journal-title":"J Med Virol"},{"key":"1816_CR75","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1165\/ajrcmb.24.2.3918","volume":"24","author":"X Wang","year":"2001","unstructured":"Wang X, Zhang Y, Amberson A, Engelhardt JF. New models of the tracheal airway define the glandular contribution to airway surface fluid and electrolyte composition. Am J Respir Cell Mol Biol. 2001;24:195\u2013202.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1816_CR76","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0070-2153(04)64003-8","volume":"64","author":"X Liu","year":"2004","unstructured":"Liu X, Driskell RR, Engelhardt JF. Airway glandular development and stem cells. Curr Top Dev Biol. 2004;64:33\u201356.","journal-title":"Curr Top Dev Biol"},{"key":"1816_CR77","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1165\/rcmb.2006-0286OC","volume":"36","author":"X Liu","year":"2007","unstructured":"Liu X, Luo M, Zhang L, Ding W, Yan Z, Engelhardt JF. Bioelectric properties of chloride channels in human, pig, ferret, and mouse airway epithelia. Am J Respir Cell Mol Biol. 2007;36:313\u201323.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1816_CR78","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq3059","volume":"229","author":"JJ Frere","year":"2022","unstructured":"Frere JJ, Serafini RA, Pryce KD, Zazhytska M, Oishi K, Golynker I, et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery. Sci Transl Med. 2022;229: eabq3059.","journal-title":"Sci Transl Med."},{"key":"1816_CR79","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","volume":"41","author":"FW Studier","year":"2005","unstructured":"Studier FW. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif. 2005;41:207\u201334.","journal-title":"Protein Expr Purif"},{"key":"1816_CR80","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/2211738511301020006","volume":"1","author":"X Cheng","year":"2013","unstructured":"Cheng X, Tsao C, Saul JM, Sylvia V, Cornet D, Christy R. Comparison of two nanoparticle formulations for localized delivery of platelet-derived growth factor (PDGF) from aligned collagen fibers. Pharm Nanotechnol. 2013;1:105\u201314.","journal-title":"Pharm Nanotechnol."},{"key":"1816_CR81","unstructured":"Cheng X, Carson K, Mcdonough J, Gourapura RG, Lee CW, Dhakal S. A liposomal subunit flu vaccine formulation. US Patent application (pending), SwRI invention disclosure docket # 3928 2017."},{"key":"1816_CR82","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/0003-2697(78)90172-0","volume":"90","author":"DW Fry","year":"1978","unstructured":"Fry DW, White JC, Goldman ID. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem. 1978;90:809\u201315.","journal-title":"Anal Biochem"},{"key":"1816_CR83","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1366\/000370209787944280","volume":"63","author":"X Cheng","year":"2009","unstructured":"Cheng X, Haggins DG, York RH, Yeni YN, Akkus O. Analysis of crystals leading to joint arthropathies by Raman spectroscopy: comparison with compensated polarized imaging. Appl Spectrosc. 2009;63:381\u20136.","journal-title":"Appl Spectrosc"},{"key":"1816_CR84","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","volume":"5","author":"MA Ramakrishnan","year":"2016","unstructured":"Ramakrishnan MA. Determination of 50% endpoint titer using a simple formula. World J Virol. 2016;5:85\u20136.","journal-title":"World J Virol"},{"key":"1816_CR85","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jviromet.2014.04.014","volume":"205","author":"LA Carolan","year":"2014","unstructured":"Carolan LA, Butler J, Rockman S, Guarnaccia T, Hurt AC, Reading P, et al. TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses. J Virol Methods. 2014;205:38\u201352.","journal-title":"J Virol Methods"},{"key":"1816_CR86","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1023\/B:BILE.0000019559.84305.47","volume":"26","author":"MW Pfaffl","year":"2004","unstructured":"Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper\u2013Excel-based tool using pair-wise correlations. Biotechnol Lett. 2004;26:509\u201315.","journal-title":"Biotechnol Lett"},{"key":"1816_CR87","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01816-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-01816-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01816-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T19:04:54Z","timestamp":1677092694000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-01816-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1816"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-01816-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]},"assertion":[{"value":"5 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in strict accordance with the recommendations by the Public Health Service Policy, USDA Regulations, National Research Council\u2019s Guide for the Care and Use of Laboratory Animals and the Federation of Animal Science Societies\u2019 Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching. All the animals were maintained, samples collected and euthanized, and all efforts were made to minimize the suffering of ferrets as per the approved institutional, state and federal regulations and policies regarding animal care and use at The Ohio State University on the Ethics for Animal Experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}